72 related articles for article (PubMed ID: 33755120)
1. Perspectives of cellular communication through tunneling nanotubes in cancer cells and the connection to radiation effects.
Matejka N; Reindl J
Radiat Oncol; 2019 Dec; 14(1):218. PubMed ID: 31796110
[TBL] [Abstract][Full Text] [Related]
2. Cellular bridges: Routes for intercellular communication and cell migration.
Zani BG; Edelman ER
Commun Integr Biol; 2010 May; 3(3):215-20. PubMed ID: 20714396
[TBL] [Abstract][Full Text] [Related]
3. Different types of cell-to-cell connections mediated by nanotubular structures.
Veranic P; Lokar M; Schütz GJ; Weghuber J; Wieser S; Hägerstrand H; Kralj-Iglic V; Iglic A
Biophys J; 2008 Nov; 95(9):4416-25. PubMed ID: 18658210
[TBL] [Abstract][Full Text] [Related]
4. [Glioblastomas exploit neuronal properties: a key to new forms of treatment?].
Venkataramani V; Winkler F
Nervenarzt; 2024 Feb; 95(2):96-103. PubMed ID: 38157044
[TBL] [Abstract][Full Text] [Related]
5. On fields, light and excitability in glioblastoma: Comment on: "The distinguishing electrical properties of cancer cells" by Di Gregorio et al.
Halatsch ME
Phys Life Rev; 2023 Dec; 47():15-16. PubMed ID: 37660430
[No Abstract] [Full Text] [Related]
6. Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion.
Wang X; Pei Z; Hossain A; Bai Y; Chen G
Cancer Biol Med; 2021 Mar; 18(3):860-74. PubMed ID: 33755378
[TBL] [Abstract][Full Text] [Related]
7. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
Suwala AK; Stichel D; Schrimpf D; Maas SLN; Sill M; Dohmen H; Banan R; Reinhardt A; Sievers P; Hinz F; Blattner-Johnson M; Hartmann C; Schweizer L; Boldt HB; Kristensen BW; Schittenhelm J; Wood MD; Chotard G; Bjergvig R; Das A; Tabori U; Hasselblatt M; Korshunov A; Abdullaev Z; Quezado M; Aldape K; Harter PN; Snuderl M; Hench J; Frank S; Acker T; Brandner S; Winkler F; Wesseling P; Pfister SM; Reuss DE; Wick W; von Deimling A; Jones DTW; Sahm F
Acta Neuropathol; 2021 Jul; 142(1):179-189. PubMed ID: 33876327
[TBL] [Abstract][Full Text] [Related]
8. TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma.
Wirsik NM; Ehlers J; Mäder L; Ilina EI; Blank AE; Grote A; Feuerhake F; Baumgarten P; Devraj K; Harter PN; Mittelbronn M; Naumann U
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):768-780. PubMed ID: 33780024
[TBL] [Abstract][Full Text] [Related]
9. Perspective: targeting VEGF-A and YKL-40 in glioblastoma - matter matters.
Holst CB; Pedersen H; Obara EAA; Vitting-Seerup K; Jensen KE; Skjøth-Rasmussen J; Lund EL; Poulsen HS; Johansen JS; Hamerlik P
Cell Cycle; 2021 Apr; 20(7):702-715. PubMed ID: 33779510
[TBL] [Abstract][Full Text] [Related]
10. γH2AX foci assay in glioblastoma: Surgical specimen versus corresponding stem cell culture.
Riedel A; Klumpp L; Menegakis A; De-Colle C; Huber SM; Schittenhelm J; Neumann M; Noell S; Tatagiba M; Zips D
Radiother Oncol; 2021 Jun; 159():119-125. PubMed ID: 33775712
[TBL] [Abstract][Full Text] [Related]
11. Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma.
Khan MB; Ruggieri R; Jamil E; Tran NL; Gonzalez C; Mugridge N; Gao S; MacDiarmid J; Brahmbhatt H; Sarkaria JN; Boockvar J; Symons M
Mol Med; 2021 Mar; 27(1):28. PubMed ID: 33765907
[TBL] [Abstract][Full Text] [Related]
12. The immune suppressive microenvironment affects efficacy of radio-immunotherapy in brain metastasis.
Niesel K; Schulz M; Anthes J; Alekseeva T; Macas J; Salamero-Boix A; Möckl A; Oberwahrenbrock T; Lolies M; Stein S; Plate KH; Reiss Y; Rödel F; Sevenich L
EMBO Mol Med; 2021 May; 13(5):e13412. PubMed ID: 33755340
[TBL] [Abstract][Full Text] [Related]
13. Silencing glioblastoma networks to make temozolomide more effective.
Winkler F
Neuro Oncol; 2021 Nov; 23(11):1807-1809. PubMed ID: 34347098
[No Abstract] [Full Text] [Related]
14. The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure.
Valdebenito S; Ono A; Rong L; Eugenin EA
NeuroImmune Pharm Ther; 2023 Jun; 2(2):169-186. PubMed ID: 37476291
[TBL] [Abstract][Full Text] [Related]
15. Brain Tumor Networks in Diffuse Glioma.
Yang Y; Schubert MC; Kuner T; Wick W; Winkler F; Venkataramani V
Neurotherapeutics; 2022 Oct; 19(6):1832-1843. PubMed ID: 36357661
[TBL] [Abstract][Full Text] [Related]
16. TNTdetect.AI: A Deep Learning Model for Automated Detection and Counting of Tunneling Nanotubes in Microscopy Images.
Ceran Y; Ergüder H; Ladner K; Korenfeld S; Deniz K; Padmanabhan S; Wong P; Baday M; Pengo T; Lou E; Patel CB
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230881
[TBL] [Abstract][Full Text] [Related]
17. Intercellular Communication in the Brain through Tunneling Nanotubes.
Khattar KE; Safi J; Rodriguez AM; Vignais ML
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267518
[TBL] [Abstract][Full Text] [Related]
18. Tunneling nanotubes, TNT, communicate glioblastoma with surrounding non-tumor astrocytes to adapt them to hypoxic and metabolic tumor conditions.
Valdebenito S; Malik S; Luu R; Loudig O; Mitchell M; Okafo G; Bhat K; Prideaux B; Eugenin EA
Sci Rep; 2021 Jul; 11(1):14556. PubMed ID: 34267246
[TBL] [Abstract][Full Text] [Related]
19. Two routes of direct intercellular communication in brain cancer.
Azorín DD; Winkler F
Biochem J; 2021 Mar; 478(6):1283-1286. PubMed ID: 33755120
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
